Yüklüyor......
Inhibitor of Apoptosis (IAP) proteins as drug targets for the treatment of cancer
Three companies, Genentech, Aegera Therapeutics/Human Genome Sciences, and Novartis, have commenced phase 1 clinical trials of inhibitor of apoptosis (IAP) antagonist ‘Smac mimetic’ compounds for the treatment of cancer. These trials represent the culmination of a line of research that commenced wit...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Biology Reports Ltd
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2948278/ https://ncbi.nlm.nih.gov/pubmed/20948609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3410/B1-79 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|